title: [Stasis priapism secondary to PGE1: transformation into high-flow priapism].
abstract: Since vasoactive agents were first introduced for the diagnosis and treatment of Erectile Dysfunction (ED), the most feared side effect has been priapism. The arrival of Prostaglandin E1 (PGE1) limited to a large extent the incidence of this complication due to its fast systemic and intracavernous metabolism. A case of stasis priapism following a low dose PGE1 injection (10 mcg) after 48 hours evolution and its surprising conversion to high flow priapism after the surgical procedures performed to solve this complication is presented here.
authors.affiliation: Servicio de Urología, Hospital Universitario de Canarias, La Laguna.
authors.forename: A
authors.initials: A
authors.lastname: Negrín Díaz
authors.forename: F
authors.initials: F
authors.lastname: Díaz Romero
authors.forename: J
authors.initials: J
authors.lastname: Fernández Ramos
authors.forename: P
authors.initials: P
authors.lastname: Gutiérrez Hernández
authors.forename: F
authors.initials: F
authors.lastname: Arteaga Serrano
authors.forename: F
authors.initials: F
authors.lastname: Bañares Baudet
mesh_terms: D000527:Alprostadil / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010413:Penis / Q000098:blood supply; D011317:Priapism / Q000139:chemically induced*; D012039:Regional Blood Flow; D014665:Vasodilator Agents / Q000009:adverse effects*
chemical_list: D014665:Vasodilator Agents; D000527:Alprostadil
vernacular_title: Priapismo de éstasis secundario a PGE1: transformación en priapismo de alto flujo.